02UW38Z
Supplement Thoracic Aorta, Descending to No Qualifier with Zooplastic Tissue, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | 2 Heart and Great Vessels |
| Operation | U Supplement |
| Body Part | W Thoracic Aorta, Descending |
| Approach | 3 Percutaneous |
| Device | 8 Zooplastic Tissue |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part
Procedure Overview
Supplement procedures add biological or synthetic material to reinforce or enhance a portion of the heart or a great vessel without removing the existing structure. Common examples include patch repair of a septal defect, reinforcing a weakened area of the aortic wall, or placing material to strengthen a valve annulus during repair.
The goal is to shore up tissue that is present but insufficient on its own, whether because of a congenital hole, an aneurysm that has thinned the vessel wall, or a valve structure that needs extra support to function properly. Unlike a replacement, the body's own tissue stays in place and the added material works alongside it.
Patients typically encounter this term in the context of congenital defect closures, aortic aneurysm repairs, and valve repair techniques that use patches, rings, or other reinforcing materials rather than swapping out the whole valve or vessel.
Anatomy & Axis Detail
Thoracic Aorta, Descending
The descending thoracic aorta runs from the aortic arch through the posterior mediastinum to the diaphragm, supplying intercostal and visceral branches along its course, and its wall can weaken from atherosclerotic disease, chronic dissection, or aneurysmal degeneration. Supplementing this segment reinforces the diseased wall using a patch, felt strip, or graft material sewn in place, distinct from replacing the vessel outright, and is chosen when the native aortic wall remains usable but structurally insufficient. Because the descending aorta lies adjacent to the spinal cord's blood supply through radicular arteries, the operative approach carries particular attention to preserving perfusion to those branches. Reports should clarify the extent of the segment addressed, since descending aortic disease often spans a variable length that affects operative planning and coding specificity.
Approach: Percutaneous
Percutaneous describes entry by needle or instrument puncture through the skin or mucous membrane to reach the site of the procedure, without cutting the tissue open or using a visualizing scope. It differs from Open in that the site itself is never exposed, and from Percutaneous Endoscopic in that no endoscope is used to see internal structures. Common examples include needle biopsies and injections.
Device: Zooplastic Tissue
Zooplastic Tissue designates material of animal origin, most often bovine or porcine, used to replace or reinforce human anatomic structures such as heart valves or grafts. It is procured from a non-human source and processed for implantation, setting it apart from autologous tissue taken from the patient's own body and from nonautologous tissue sourced from another human donor.
Coding & Documentation
Coders assign Supplement when the note documents that material, biological or synthetic, was added to reinforce or augment existing anatomy, such as closing a septal defect with a patch or buttressing a vessel wall. The documentation should identify the material used and confirm that native tissue was not removed and replaced, only strengthened.
The most frequent error is confusing patch closure of a defect, which is Supplement, with actual replacement of a structure, which requires taking out the original part. Another common mistake is missing that some valve repairs combine Supplement for annuloplasty ring placement with Repair for other steps done in the same operative session, each of which needs its own code.